Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hepatitis C, Chronic × Viusid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Papillomavirus Infections 1 Hepatitis C, Chronic 1 Fibrosis 1 Condylomata Acuminata 1

Interventions

Ribavirin 4 ledipasvir 3 peginterferon alfa-2a 2 ledipasvir, sofosbuvir drug combination 2 Sofosbuvir 2 sofosbuvir-velpatasvir drug combination 1 daclatasvir 1 Viusid 1 Simeprevir 1 Introns 1 Dietary Supplements 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00502086 2011-02-11

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Catalysis SL

Phase 3 Completed

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡